NCT05021198

Brief Summary

The NoCVT study will investigate CVT (2014-2023) in a large Norwegian population (\> 3 millions) using several approaches combining existing health registries, clinical databases and new prospectively collected clinical data to explore epidemiology, risk factors, diagnostics, treatment, and the long-term prognosis of CVT.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Jan 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Jan 2014Jan 2027

Study Start

First participant enrolled

January 1, 2014

Completed
7.4 years until next milestone

First Submitted

Initial submission to the registry

May 27, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 25, 2021

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

February 5, 2025

Status Verified

February 1, 2025

Enrollment Period

13 years

First QC Date

May 27, 2021

Last Update Submit

February 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mortality of CVT in a Norwegian population

    Number dead vs total number of cases

    Baseline, 3 months, 12 months, 24 months and 5 years

Secondary Outcomes (20)

  • Health care utilisation after CVT

    Baseline to five years

  • Re-admission after CVT

    Baseline to five years

  • New diagnosis after CVT

    Baseline to five years

  • New prescriptions after CVT

    Baseline to five years

  • Nursing home after CVT

    Baseline to five years

  • +15 more secondary outcomes

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

A retrospective hospital-based chart review will be conducted at 13 different hospitals covering approximately 3 million inhabitants in Norway. More precis, a validated ICD-10 search will be made in the clinical database for patients with the diagnosis of CVT in the period between January 1, 2014, and December 31, 2023. Data from the clinical databases at these hospitals will be linked with the mandatory National Health Registries for baseline data and prospectively collected follow-up data. The National Health Registries involved are Statistics Norway (SSB), Norwegian Prescription Database (NorPD), Norwegian Patient Registry (NPR) and Cause of Death Registry (DÅR). In addition a clinical follow-up interview will be conducted with emphasis on long-term outcomes.

You may qualify if:

  • A diagnosis of CVT 2014-2023 from the 13 participating primary hospitals

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Akershus University Hospital

Lørenskog, 1478, Norway

RECRUITING

Related Publications (1)

  • Kristoffersen ES, Harper CE, Vetvik KG, Zarnovicky S, Hansen JM, Faiz KW. Incidence and Mortality of Cerebral Venous Thrombosis in a Norwegian Population. Stroke. 2020 Oct;51(10):3023-3029. doi: 10.1161/STROKEAHA.120.030800. Epub 2020 Sep 4.

    PMID: 32883194BACKGROUND

MeSH Terms

Conditions

Intracranial Thrombosis

Condition Hierarchy (Ancestors)

Intracranial Embolism and ThrombosisCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesThromboembolismEmbolism and Thrombosis

Study Officials

  • Espen Saxhaug Kristoffersen, MD, PhD

    University Hospital, Akershus

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Espen Saxhaug Kristoffersen, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

May 27, 2021

First Posted

August 25, 2021

Study Start

January 1, 2014

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

February 5, 2025

Record last verified: 2025-02

Locations